Get the Stockscreener App
23.72
1.70%
-0.41
After Hours:
23.72
Xencor Inc stock is traded at $23.72, with a volume of 877.48K.
It is down -1.70% in the last 24 hours and down -6.39% over the past month.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
See More
Previous Close:
$24.13
Open:
$24.07
24h Volume:
877.48K
Relative Volume:
1.55
Market Cap:
$1.66B
Revenue:
$133.62M
Net Income/Loss:
$-177.37M
P/E Ratio:
-8.2076
EPS:
-2.89
Net Cash Flow:
$23.50M
1W Performance:
+0.04%
1M Performance:
-6.39%
6M Performance:
+30.12%
1Y Performance:
+15.20%
1-Day Range:
$23.69
$24.66
1-Week Range:
$22.79
$24.66
52-Week Range:
$15.31
$27.24
Xencor Inc Stock (XNCR) Company Profile
Name
Xencor Inc
Sector
Industry
Phone
626-305-5900
Address
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
23.72 | 1.66B | 133.62M | -177.37M | 23.50M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
402.49 | 103.65B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.26 | 78.71B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
645.37 | 38.59B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.15 | 30.07B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.21 | 28.82B | 3.30B | -501.07M | 1.03B | -2.1146 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Initiated | Wells Fargo | Overweight |
| Dec-02-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-16-24 | Reiterated | BTIG Research | Buy |
| Feb-28-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-19-23 | Initiated | BofA Securities | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Oct-13-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Jul-06-22 | Resumed | Canaccord Genuity | Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Jan-21-22 | Initiated | SMBC Nikko | Outperform |
| Dec-15-21 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Feb-24-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Mar-04-20 | Initiated | Barclays | Underweight |
| Feb-25-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-30-20 | Initiated | RBC Capital Mkts | Outperform |
| Nov-20-19 | Resumed | Guggenheim | Neutral |
| Aug-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-13-19 | Initiated | Mizuho | Buy |
| Apr-12-19 | Initiated | Guggenheim | Buy |
| Mar-27-19 | Initiated | Berenberg | Buy |
| Mar-15-19 | Initiated | Raymond James | Outperform |
| Sep-10-18 | Resumed | BTIG Research | Buy |
| Mar-28-18 | Resumed | Leerink Partners | Outperform |
| Mar-02-17 | Initiated | Instinet | Neutral |
| Mar-02-17 | Reiterated | Wedbush | Outperform |
| Oct-04-16 | Initiated | Piper Jaffray | Overweight |
| Dec-22-15 | Initiated | Canaccord Genuity | Buy |
| Aug-05-15 | Reiterated | MLV & Co | Buy |
| Feb-12-15 | Reiterated | Oppenheimer | Outperform |
| Jan-28-15 | Reiterated | MLV & Co | Buy |
| Jul-11-14 | Initiated | Oppenheimer | Outperform |
View All
Xencor Inc Stock (XNCR) Latest News
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Principal Financial Group Inc. - Defense World
Is Xencor (NASDAQ:XNCR) Using Too Much Debt? - Simply Wall St
(XNCR) Investment Analysis - Stock Traders Daily
Geode Capital Management LLC Raises Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
26,831 Shares in Xencor, Inc. (NASDAQ:XNCR) Purchased by Sanctuary Advisors LLC - Defense World
Sanctuary Advisors LLC Takes $540,000 Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Barclays PLC Raises Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Barclays PLC Increases Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Intrahepatic Cholangiocarcinoma Pipeline Insights 2024: Therapies, Clinical Trials, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapeutics - The Globe and Mail
Fmr LLC Buys 12,729 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Stake Increased by Jane Street Group LLC - MarketBeat
State Street Corp Reduces Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
When (XNCR) Moves Investors should Listen - Stock Traders Daily
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Xencor (NASDAQ:XNCR) Earns Overweight Rating from Analysts at Wells Fargo & Company - Defense World
Xencor's SWOT analysis: biotech stock balances promise and challenges - Investing.com
Xencor's SWOT analysis: biotech stock balances promise and challenges By Investing.com - Investing.com Canada
Wells Fargo Initiates Coverage of Xencor (XNCR) with Overweight Recommendation - MSN
All You Need to Know About Xencor (XNCR) Rating Upgrade to Buy - MSN
Xencor (NASDAQ:XNCR) Now Covered by Wells Fargo & Company - MarketBeat
Rockefeller Capital Management L.P. Invests $205,000 in Xencor, Inc. (NASDAQ:XNCR) - Defense World
The Manufacturers Life Insurance Company Reduces Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Charles Schwab Investment Management Inc. Has $12.61 Million Holdings in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
(XNCR) Technical Pivots with Risk Controls - Stock Traders Daily
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
46,700 Shares in Xencor, Inc. (NASDAQ:XNCR) Purchased by Polar Asset Management Partners Inc. - MarketBeat
Readystate Asset Management LP Buys New Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Wall Street Analysts Think Xencor (XNCR) Could Surge 31.58%: Read This Before Placing a Bet - MSN
RTW Investments LP Takes $11.56 Million Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
RA Capital Management L.P. Makes New Investment in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Point72 Asset Management L.P. Purchases 1,858,440 Shares of Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Xencor director Montgomery sells $397,930 in stock - Investing.com India
Xencor director Montgomery sells $397,930 in stock By Investing.com - Investing.com Canada
Fed. Circ. Judge Condemns 'Nonsense' Law In Antibody Fight - Law360
Piper Sandler Upgrades Xencor (XNCR) - MSN
Xencor, Inc.'s (NASDAQ:XNCR) 26% Share Price Surge Not Quite Adding Up - Simply Wall St
Xencor stock hits 52-week high at $26.89 amid robust gains - Investing.com Canada
Piper Sandler upgrades Xencor stock, highlights expanding pipeline and Phase I/II data - Investing.com Nigeria
Xencor stock hits 52-week high at $26.89 amid robust gains By Investing.com - Investing.com South Africa
Baker BROS. Advisors LP Purchases 125,000 Shares of Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Critical Insights From Xencor Analyst Ratings: What You Need To Know - Inkl
Erste Asset Management GmbH Takes Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Invests $362,000 in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Victory Capital Management Inc. Trims Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Braidwell LP Makes New Investment in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Short Interest in Xencor, Inc. (NASDAQ:XNCR) Declines By 18.2% - MarketBeat
Thrivent Financial for Lutherans Raises Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Thrivent Financial for Lutherans Acquires 65,180 Shares of Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Xencor Inc Stock (XNCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.27%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):